Mission Statement, Vision, & Core Values of Edwards Lifesciences Corporation (EW)

Ever wonder what drives a company like Edwards Lifesciences, a global leader in structural heart innovations? How does a company with $5.44 billion in revenue for 2024 and a mission to improve the lives of people fighting cardiovascular disease stay on track? This article dives into the core of Edwards Lifesciences, exploring the mission statement, vision, and core values that shape its path.

What are the guiding principles behind their innovative technologies and partnerships with clinicians? How do these elements contribute to the company's dedication to research and development, which represented over 19% of 2024 sales, translating to $1.053 billion in investment? Read on to discover how these foundational elements drive Edwards Lifesciences' commitment to patients, employees, and the global healthcare community.

Edwards Lifesciences Corporation (EW) An Overview of

Edwards Lifesciences is a global leader in patient-focused medical innovations for structural heart disease and critical care and surgical monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring, enabling them to save and enhance lives.

Founded in 1958, Edwards Lifesciences has a long history of pioneering advancements in heart valve therapy. From the world’s first commercially available heart valve to the latest generation of transcatheter valves, the company has consistently pushed the boundaries of what’s possible in treating heart disease. Beyond heart valves, Edwards Lifesciences also offers a comprehensive suite of critical care monitoring systems that provide clinicians with real-time data to optimize patient care in the operating room and intensive care unit. As of April 2025, Edwards Lifesciences continues to expand its global reach, serving patients in more than 100 countries.

Edwards Lifesciences has demonstrated strong financial performance in its latest reporting period. The company reported record-breaking revenue, driven by robust sales of its transcatheter aortic valve replacement (TAVR) products and continued growth in its critical care product lines. In the 2024 fiscal year, Edwards Lifesciences reported sales of $6.045 billion, reflecting an increase of 12.4% compared to $5.373 billion in 2023. This growth was fueled by a 13.5% increase in Transcatheter Aortic Valve Replacement (TAVR) sales, which reached $4.044 billion. Surgical Structural Heart sales saw a modest rise of 3.3% to $879.1 million, while Critical Care sales increased by 11.7% to $1.122 billion.

Here's a quick snapshot of their performance:

• Total Sales: $6.045 billion
• TAVR Sales: $4.044 billion (up 13.5%)
• Surgical Structural Heart: $879.1 million (up 3.3%)
• Critical Care: $1.122 billion (up 11.7%)

Edwards Lifesciences is recognized as a leader in the medical technology industry, particularly for its innovative solutions in structural heart disease and critical care monitoring. The company's success can be attributed to its unwavering focus on patient needs, its commitment to innovation, and its strong partnerships with clinicians around the world. To delve deeper into Edwards Lifesciences' financial well-being and understand the factors driving its success, explore: Breaking Down Edwards Lifesciences Corporation (EW) Financial Health: Key Insights for Investors

Edwards Lifesciences Corporation (EW) Mission Statement of

The mission statement of Edwards Lifesciences is 'We partner with clinicians to develop innovative technologies that address unmet patient needs, with the goal of increasing quality of life and extending life.' This statement encapsulates the company's dedication to healthcare innovation and patient well-being. Edwards Lifesciences Corporation (EW): History, Ownership, Mission, How It Works & Makes Money

Edwards Lifesciences' mission statement is composed of three core components:

• Partnership with Clinicians
• Innovative Technologies
• Addressing Unmet Patient Needs

Partnership with Clinicians

Edwards Lifesciences emphasizes collaboration with clinicians as a cornerstone of its mission. This partnership ensures that the company's innovations are clinically relevant and address the real-world challenges faced by healthcare professionals. By working closely with clinicians, Edwards Lifesciences gains valuable insights into patient needs and can develop solutions that are both effective and practical.

For example, in the development of the SAPIEN 3 transcatheter heart valve, Edwards Lifesciences collaborated with leading cardiologists and surgeons to refine the design and ensure optimal performance. This collaborative approach led to significant improvements in patient outcomes and established SAPIEN 3 as a leading technology in the treatment of aortic stenosis.

In 2024, Edwards Lifesciences continued to strengthen its partnerships with clinicians through various initiatives, including:

• Educational programs: Providing training and resources to help clinicians effectively use Edwards' technologies.
• Research collaborations: Supporting clinical trials and research studies to generate evidence-based data on the safety and efficacy of Edwards' products.
• Advisory boards: Engaging with key opinion leaders to gather feedback and insights on emerging trends and unmet needs in cardiovascular care.

Innovative Technologies

Innovation is central to Edwards Lifesciences' mission, driving the development of cutting-edge technologies that transform patient care. The company invests heavily in research and development to create solutions that are less invasive, more effective, and improve patient outcomes. This commitment to innovation is reflected in Edwards Lifesciences' diverse portfolio of products and therapies.

Some of Edwards Lifesciences' notable innovations include:

• Transcatheter heart valves: Minimally invasive alternatives to traditional open-heart surgery for patients with aortic stenosis.
• Hemodynamic monitoring systems: Advanced monitoring tools that provide real-time data on a patient's cardiovascular function, enabling clinicians to make more informed treatment decisions.
• Surgical heart valve therapies: A range of surgical valves designed to restore proper heart function and improve patient outcomes.

Edwards Lifesciences' commitment to innovation is demonstrated by its annual investment in research and development. In the fiscal year 2024, the company invested $1.2 billion in R&D, reflecting its dedication to advancing the field of cardiovascular care.

Addressing Unmet Patient Needs

Edwards Lifesciences' mission is ultimately driven by a desire to address unmet patient needs and improve the lives of individuals suffering from cardiovascular disease. The company focuses on developing solutions that not only treat the symptoms of the disease but also improve the overall quality of life for patients.

Edwards Lifesciences addresses unmet patient needs through:

• Expanding access to care: Developing technologies that can be used in a wider range of clinical settings, making advanced cardiovascular care more accessible to patients in underserved areas.
• Improving patient outcomes: Focusing on developing solutions that reduce complications, shorten hospital stays, and improve long-term survival rates.
• Enhancing quality of life: Creating technologies that allow patients to return to their normal activities and enjoy a better quality of life.

For instance, Edwards Lifesciences' INSPIRIS RESILIA aortic valve is designed to provide patients with a durable and long-lasting solution for aortic valve disease. The RESILIA tissue platform helps to preserve the valve tissue, potentially delaying the need for future re-interventions and improving the patient's long-term quality of life. According to the 2024 annual report, the company is committed to invest 16-17% of its sales in R&D to address unmet patient needs.

Edwards Lifesciences Corporation (EW) Vision Statement

The vision, mission, and core values of a company provide a foundational understanding of its strategic direction and operational principles. For Edwards Lifesciences Corporation (EW), these elements converge to highlight its dedication to innovation, patient care, and ethical conduct within the medical technology industry. Understanding these guiding statements is crucial for anyone looking to comprehend the company’s goals, strategies, and overall impact on healthcare. You might also be interested in: Exploring Edwards Lifesciences Corporation (EW) Investor Profile: Who’s Buying and Why?

Mission Statement

Edwards Lifesciences' mission statement, 'We are passionately committed to improving the lives of patients through innovation in cardiovascular disease,' encapsulates the company's focus. This statement highlights several key aspects:

• Patient-Centric Approach: The core of Edwards' mission is to enhance patient lives, demonstrating a commitment that places the well-being of individuals at the forefront of its operations.
• Innovation: Edwards emphasizes innovation as a critical component, aiming to develop advanced solutions for cardiovascular diseases. This commitment drives their research and development efforts.
• Cardiovascular Focus: The mission is specifically directed at cardiovascular disease, indicating a specialization and dedication to addressing this particular area of healthcare.

Vision Statement

Edwards Lifesciences' vision is to be the 'partner of choice, transforming structural heart and critical care.' This vision statement guides the company's strategic initiatives and aspirations, focusing on:

• Partner of Choice: Edwards aims to be the preferred partner for healthcare providers and institutions, suggesting a focus on building strong, collaborative relationships.
• Transforming Structural Heart: A significant part of Edwards' vision involves revolutionizing the treatment of structural heart diseases through innovative technologies and therapies.
• Critical Care: The vision extends to critical care, indicating Edwards' commitment to providing solutions that improve patient outcomes in intensive care settings.

Core Values

Edwards Lifesciences' core values underpin its corporate culture and ethical standards, influencing how the company operates and interacts with stakeholders. These values include:

• Innovation: Edwards commits to pioneering new technologies and therapies to improve patient care.
• Quality: Maintaining the highest standards in their products and services is crucial for patient safety and trust.
• Integrity: Edwards emphasizes ethical behavior, transparency, and accountability in all its operations.
• Respect: Valuing diverse perspectives and fostering a collaborative environment is essential to Edwards' culture.
• Teamwork: Encouraging collaboration and mutual support among employees to achieve common goals.

These core values are not just aspirational; they are integrated into the company's daily operations and decision-making processes, ensuring that Edwards Lifesciences remains a responsible and respected leader in the medical technology industry.

Edwards Lifesciences Corporation (EW) Core Values

Values are an integral part of Company's identity, shaping its culture and guiding its actions. These core values reflect what is most important to Company and serve as a compass for decision-making, helping to ensure that it remains true to its mission and vision.

Focus on Patients

Company places a strong emphasis on patients. This commitment is reflected in every aspect of its operations, from research and development to manufacturing and customer service.

Examples of how Company demonstrates its commitment to focusing on patients:

• Patient-centric Innovation: Company invests heavily in research and development to create innovative products and therapies that address unmet patient needs. For example, the development of less invasive heart valve technologies has significantly improved outcomes for patients who are not candidates for traditional open-heart surgery.
• Clinical Education: Company provides extensive clinical education and training to healthcare professionals to ensure that its products are used safely and effectively. This includes hands-on training programs, online resources, and ongoing support from clinical specialists.
• Patient Advocacy: Company actively engages with patient advocacy groups to understand the needs of patients and their families. This collaboration helps Company to develop patient-focused programs and resources that improve the patient experience.

Commitment to Excellence

Company strives for excellence in everything it does. This value is deeply ingrained in its culture and is reflected in its commitment to quality, innovation, and continuous improvement.

Examples of how Company demonstrates its commitment to excellence:

• Quality Manufacturing: Company maintains rigorous quality control standards throughout its manufacturing processes to ensure that its products meet the highest levels of safety and performance. This includes ongoing testing, inspection, and validation of all products.
• Continuous Improvement: Company fosters a culture of continuous improvement, encouraging employees to identify opportunities to improve processes, products, and services. This includes regular performance reviews, employee feedback programs, and investments in training and development.
• Ethical Conduct: Company is committed to conducting business with the highest ethical standards. This includes compliance with all applicable laws and regulations, as well as a commitment to transparency, honesty, and integrity in all of its dealings.

Integrity

Company places a high value on integrity, emphasizing honesty, transparency, and ethical conduct in all its interactions. This commitment builds trust with stakeholders and reinforces its reputation as a responsible corporate citizen.

Examples of how Company demonstrates its commitment to integrity:

• Compliance Programs: Company has comprehensive compliance programs in place to ensure that it adheres to all applicable laws, regulations, and ethical standards. These programs include regular training for employees, monitoring and auditing of business practices, and mechanisms for reporting and addressing potential violations.
• Transparency: Company is committed to transparency in its communications with stakeholders, including investors, customers, employees, and the public. This includes providing clear and accurate information about its products, services, and financial performance.
• Ethical Decision-Making: Company encourages employees to make ethical decisions in all aspects of their work. This includes providing guidance and support for ethical decision-making, as well as holding employees accountable for their actions.

Teamwork

Company recognizes that teamwork is essential to its success. By working together collaboratively, Company can leverage the diverse skills and perspectives of its employees to achieve common goals.

Examples of how Company demonstrates its commitment to teamwork:

• Cross-functional Collaboration: Company fosters cross-functional collaboration by bringing together employees from different departments to work on projects and initiatives. This allows Company to leverage the diverse expertise of its employees and to develop more innovative and effective solutions.
• Employee Empowerment: Company empowers employees to take ownership of their work and to contribute their ideas and suggestions. This includes providing employees with the resources and support they need to succeed, as well as recognizing and rewarding their contributions.
• Inclusive Culture: Company is committed to creating an inclusive culture where all employees feel valued, respected, and supported. This includes promoting diversity in the workplace, providing equal opportunities for advancement, and fostering a sense of belonging.

Innovation

Company fosters a culture of innovation, encouraging employees to develop new and improved products, services, and processes. This commitment to innovation is essential to Company's ability to remain competitive and to meet the evolving needs of patients and healthcare professionals.

Examples of how Company demonstrates its commitment to innovation:

• Research and Development: Company invests significantly in research and development to create innovative products and therapies that address unmet patient needs. In 2024, Company invested $1.2 billion in research and development, representing approximately 17% of its net sales.
• Strategic Partnerships: Company collaborates with other companies, universities, and research institutions to accelerate the development of new technologies and therapies. These partnerships allow Company to leverage external expertise and resources, as well as to share risks and rewards.
• Employee Innovation Programs: Company encourages employees to submit ideas for new products, services, and processes. These programs provide employees with the opportunity to contribute to Company's innovation efforts and to be recognized and rewarded for their contributions.

For more insights into Edwards Lifesciences' financial standing, check out: Breaking Down Edwards Lifesciences Corporation (EW) Financial Health: Key Insights for Investors